PropertyValue
?:abstract
  • In December 2019, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China causing coronavirus disease-2019 (COVID-19). Numerous studies have shown varying degrees of liver damage in patients infected with SARS-CoV-2. However, in previous case studies of COVID-19, the exact cause of liver injury has not been clearly elucidated, nor is there clear evidence of the interaction between liver injury and COVID-19. This study will analyze the causes of liver injury in COVID-19 and the influence of liver-related complications on the treatment and prognosis of COVID-19.
?:creator
?:doi
  • 10.3748/wjg.v26.i19.2286
?:doi
?:journal
  • World_J_Gastroenterol
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/e2cdfd34a131c6328885a9f7f7955a3658497ecf.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7243650.xml.json
?:pmcid
?:pmid
?:pmid
  • 32476793.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Liver diseases in COVID-19: Etiology, treatment and prognosis
?:type
?:year
  • 2020-05-21

Metadata

Anon_0  
expand all